MoneyWorks4Me

Hester Biosciences informs about board meeting

18 Jul 2019 Evaluate

Hester Biosciences has informed that the meeting of the Board of Directors of the Company is scheduled on 31/07/2019 to consider and approve the Standalone and Consolidated Unaudited Financial Results for the quarter ended on 30 June 2019.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1748.90
Dr. Reddys Labs. 1214.10
Cipla 1312.85
Lupin 1954.80
Zydus Lifesciences 1124.00
View more..